Viveve Medical, Inc. financial data

Symbol
VIVE on OTC
Industry
Electromedical & Electrotherapeutic Apparatus
Location
345 Inverness Drive South, Building B, Suite 250, Englewood, CO
State of incorporation
DE
Fiscal year end
December 31
Former names
PLC SYSTEMS INC (to 9/19/2014)
Latest financial report
10-Q - Q3 2022 - Nov 10, 2022

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 176 % -74.1%
Quick Ratio 17.5 % -75.9%
Debt-to-equity 134 % +178%
Return On Equity -290 % -184%
Return On Assets -124 % -79.7%
Operating Margin -310 % -3.83%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 10.7M shares +1.14%
Common Stock, Shares, Outstanding 10.7M shares +0.91%
Common Stock, Value, Issued 1K USD 0%
Weighted Average Number of Shares Outstanding, Basic 10.7M shares +0.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 6.83M USD +2.39%
Research and Development Expense 8.72M USD +6.55%
Operating Income (Loss) -21.1M USD -6.3%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -23M USD -12.4%
Earnings Per Share, Basic -0.59 USD/shares +11.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 5.91M USD -73.9%
Accounts Receivable, after Allowance for Credit Loss, Current 860K USD +67.3%
Inventory, Net 1.62M USD -24.9%
Assets, Current 9.6M USD -65%
Property, Plant and Equipment, Net 1.01M USD -39.9%
Other Assets, Noncurrent 1.54M USD +137%
Assets 12.2M USD -60%
Accounts Payable, Current 1.11M USD -14.2%
Employee-related Liabilities, Current 557K USD +28%
Accrued Liabilities, Current 4.1M USD +60.4%
Liabilities, Current 10.8M USD +182%
Other Liabilities, Noncurrent 133K USD -89%
Liabilities 11M USD +9.49%
Retained Earnings (Accumulated Deficit) -259M USD -9.76%
Stockholders' Equity Attributable to Parent 1.18M USD -94.2%
Liabilities and Equity 12.2M USD -60%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -5.09M USD -56.4%
Net Cash Provided by (Used in) Financing Activities 19M USD -24.8%
Net Cash Provided by (Used in) Investing Activities -49K USD +42.4%
Common Stock, Shares Authorized 75M shares 0%
Common Stock, Shares, Issued 10.7M shares +0.91%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -5.12M USD -123%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Payments to Acquire Property, Plant, and Equipment 49K USD -42.4%
Lessee, Operating Lease, Liability, to be Paid 425K USD -39.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 67K USD -76.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 287K USD +2.87%
Operating Lease, Weighted Average Discount Rate, Percent 0.13 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 39K USD -61.8%
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Operating Lease, Payments 69K USD -8%
Additional Paid in Capital 260M USD +1.49%
Depreciation, Depletion and Amortization 204K USD -37.8%
Share-based Payment Arrangement, Expense 3.75M USD +10.1%
Interest Expense 1.11M USD +13.9%